Effects of Bundled Supportive Interventions on Preterm Infants' Stress-Related Outcomes During Invasive Procedures
1 other identifier
interventional
66
0 countries
N/A
Brief Summary
The proposed 2-year study has two specific aims: (1) to examine the effects of a "bundle" of supportive interventions on preterm infants' stress (salivary cortisol and dehydroepiandrosterone \[DHEA\] levels and physiological signals of infant distress), sleep, and physical activity in the NICU, and (2) to explore the relationships among preterm infants' salivary cortisol and DHEA levels, physiological signals of infant distress, sleep, and physical activity. This randomized controlled trial will adopt a longitudinal repeated-measures design to examine the effects of bundled supportive interventions on preterm infants' stress (salivary cortisol and DHEA levels \[using ELISA kit\] and physiological signals of infant distress \[using bedside electrocardiographic monitors\]), sleep and physical activity (using ankle actigraphy) during their NICU hospitalization. Preterm infants (N=120) meeting the study criteria will be randomly assigned to one of two conditions: (1) control condition: usual NICU care + positioning + gentle touch +routine kangaroo mother care (KMC) \< 20 minutes; (2) experimental condition: the bundle of supportive interventions (usual NICU care +positioning + gentle touch + modulating infant states + facilitated tucking + non-nutritive sucking + oral sucrose+ routine KMC \> 45 minutes. Outcome variables will include infants' biological responses to stress (salivary cortisol, salivary DHEA, and physiological signals of infant distress), sleep patterns, and physical activity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2016
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2016
CompletedFirst Submitted
Initial submission to the registry
December 29, 2016
CompletedFirst Posted
Study publicly available on registry
January 5, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2018
CompletedNovember 3, 2020
October 1, 2020
1.4 years
December 29, 2016
October 31, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Preterm infant salivary cortisol
Accessed by salivary cortisol ELISA kit
up to 3 months
Secondary Outcomes (4)
Preterm infant sleep
up to 3 months
Preterm infant physiological signals of infant distress
up to 3 months
All preterm infants' physical activity are accessed by using Actigraphy
up to 3 months
Preterm infant salivary DHEA levels
up to 3 months
Study Arms (2)
control condition
ACTIVE COMPARATORPreterm infants in the control condition will receive only usual NICU care, plus positioning and gentle touch during intrusive procedures.
experimental condition
EXPERIMENTALThe bundle of supportive interventions will be designed to alleviate preterm infants' stress/pain from birth to discharge from the hospital NICU.
Interventions
usual NICU care +positioning + gentle touch + modulating infant states + facilitated tucking + NNS+ oral sucrose+ routine KMC \> 45 minutes
usual NICU care + positioning + gentle touch +routine KMC \< 20 minutes
Eligibility Criteria
You may qualify if:
- (1) gestational age (GA) \> 28 weeks and \< 37 weeks
- (2) birth weight \< 2100g
- (3) stable condition (score \< 22 on the Neonatal Therapeutic Intervention Scoring System \[NTISS\] for disease severity)
- (4) parents can speak, read and write Chinese
- (5) parents have no history of drug/alcohol abuse
- (6) parents agree to participate
You may not qualify if:
- (1) congenital anomalies
- (2) neurologic impairment including convulsion, intraventricular hemorrhage \> grade II or periventricular leukomalacia
- (3) documented congenital or nosocomial (infection acquired at hospital after birth) sepsis
- (4) surgery
- (5) severe medical conditions requiring treatments such as cortisol supplementation, sedatives, muscle relaxants, antiepileptic, or analgesic drugs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Jen-Jiuan Liaw, Professor
Professor, School of Nursing, 1National Defense Medical Center, Taipei, Taiwan, ROC.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Investigator, National Defense Medical Center, Taiwan
Study Record Dates
First Submitted
December 29, 2016
First Posted
January 5, 2017
Study Start
March 1, 2016
Primary Completion
August 1, 2017
Study Completion
May 1, 2018
Last Updated
November 3, 2020
Record last verified: 2020-10
Data Sharing
- IPD Sharing
- Will not share